Skip to main content
. 2013 Oct 17;14(1):85. doi: 10.1186/1129-2377-14-85

Figure 1.

Figure 1

Differences between MWoA patients and healthy subjects in ReHo values. a. MWoA patients with ST disease duration; b. MWoA patients with LT disease duration; p < 0.01, FDR corrected; Warm colors indicate ReHo increases in MWoA patients; cool colors indicate ReHo decreases in MWoA patients.

HHS Vulnerability Disclosure